Two dose HPV vaccine effective in treating genital warts, study finds

New research offers the first published clinical evidence to support new recommendations by the Center for Disease Control and Prevention (CDC) for a two-dose HPV vaccine to prevent genital warts. Researchers found that the two-dose human papillomavirus (HPV) vaccine provides the same level of protection against genital warts as three doses, when given as directed. (Mehr in: Cancer News — ScienceDaily)